NASDAQ:AMGN - Amgen Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $254.08
  • Forecasted Upside: 15.25 %
  • Number of Analysts: 28
  • Breakdown:
  • 1 Sell Ratings
  • 12 Hold Ratings
  • 15 Buy Ratings
  • 0 Strong Buy Ratings
$220.46
▼ -1.76 (-0.79%)
1 month | 3 months | 12 months
Get New Amgen Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AMGN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AMGN

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$254.08
▲ +15.25% Upside Potential
This price target is based on 28 analysts offering 12 month price targets for Amgen in the last 3 months. The average price target is $254.08, with a high forecast of $304.00 and a low forecast of $185.00. The average price target represents a 15.25% upside from the last price of $220.46.
Buy
The current consensus among 28 investment analysts is to buy stock in Amgen. This rating has held steady since April 2020, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 9 buy ratings
  • 8 hold ratings
  • 1 sell ratings
6/3/2019
  • 0 strong buy ratings
  • 10 buy ratings
  • 8 hold ratings
  • 0 sell ratings
9/1/2019
  • 0 strong buy ratings
  • 12 buy ratings
  • 9 hold ratings
  • 0 sell ratings
11/30/2019
  • 0 strong buy ratings
  • 14 buy ratings
  • 10 hold ratings
  • 1 sell ratings
2/28/2020
  • 0 strong buy ratings
  • 15 buy ratings
  • 12 hold ratings
  • 1 sell ratings
5/28/2020
  • 0 strong buy ratings
  • 16 buy ratings
  • 12 hold ratings
  • 1 sell ratings
8/26/2020
  • 0 strong buy ratings
  • 15 buy ratings
  • 12 hold ratings
  • 1 sell ratings
10/25/2020
  • 0 strong buy ratings
  • 15 buy ratings
  • 12 hold ratings
  • 1 sell ratings
11/24/2020

Latest Recommendations

  • 0 strong buy ratings
  • 15 buy ratings
  • 12 hold ratings
  • 1 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/16/2020OppenheimerLower Price TargetOutperform$280.00 ➝ $274.00Low
i
Rating by Jay Olson at Oppenheimer Holdings Inc.
11/11/2020OppenheimerInitiated CoveragePositive ➝ Buy$275.00 ➝ $280.00Low
i
Rating by Jay Olson at Oppenheimer Holdings Inc.
11/2/2020MizuhoLower Price TargetNeutral$260.00 ➝ $215.00Low
i
10/29/2020Cantor FitzgeraldLower Price TargetOverweight$279.00 ➝ $278.00Low
i
10/29/2020BMO Capital MarketsLower Price TargetOutperform$308.00 ➝ $304.00Low
i
10/29/2020JPMorgan Chase & Co.Lower Price TargetNeutral$232.00 ➝ $222.00Medium
i
10/29/2020SVB LeerinkLower Price TargetMarket Perform$261.00 ➝ $243.00Medium
i
10/29/2020Bank of AmericaLower Price TargetBuy$275.00 ➝ $265.00Medium
i
10/29/2020Morgan StanleyBoost Price TargetMarket Perform ➝ Overweight$273.00 ➝ $275.00Medium
i
10/29/2020BarclaysLower Price TargetEqual Weight$250.00 ➝ $242.00Low
i
10/28/2020UBS GroupInitiated CoverageNeutral$232.00High
i
10/27/2020Credit Suisse GroupLower Price TargetOutperform$286.00 ➝ $284.00Low
i
10/26/2020Raymond JamesUpgradeMarket Perform ➝ Outperform$255.00Medium
i
10/22/2020OppenheimerLower Price TargetOutperform$280.00 ➝ $275.00Low
i
Rating by Jay Olson at Oppenheimer Holdings Inc.
10/15/2020Royal Bank of CanadaReiterated RatingHold$223.00Medium
i
10/13/2020Morgan StanleyLower Price TargetOverweight$281.00 ➝ $273.00Low
i
10/12/2020TruistUpgradeHold ➝ BuyLow
i
10/9/2020TruistDowngradeBuy ➝ Hold$251.00Medium
i
10/9/2020Sanford C. BernsteinDowngradeOutperform ➝ Market PerformMedium
i
10/6/2020Raymond JamesReiterated RatingOutperform ➝ Market PerformMedium
i
10/6/2020OppenheimerBoost Price TargetPositive ➝ Outperform$270.00 ➝ $280.00Medium
i
Rating by Jay Olson at Oppenheimer Holdings Inc.
9/23/2020William BlairReiterated RatingHoldMedium
i
9/22/2020JPMorgan Chase & Co.Reiterated RatingHoldHigh
i
9/21/2020OppenheimerReiterated RatingBuy$270.00Medium
i
Rating by Jay Olson at Oppenheimer Holdings Inc.
7/30/2020SunTrust BanksBoost Price TargetBuy$254.00 ➝ $268.00Low
i
7/29/2020Credit Suisse GroupReiterated RatingBuyLow
i
7/29/2020Wells Fargo & CompanyBoost Price TargetEqual Weight ➝ In-Line$237.00 ➝ $247.00Low
i
7/29/2020Jefferies Financial GroupBoost Price TargetBuy$285.00 ➝ $300.00Low
i
7/29/2020Royal Bank of CanadaLower Price TargetSector Perform$236.00 ➝ $223.00High
i
7/29/2020Morgan StanleyLower Price TargetOverweight$285.00 ➝ $281.00Medium
i
7/29/2020SVB LeerinkBoost Price TargetMarket Perform$253.00 ➝ $261.00Medium
i
7/29/2020Cantor FitzgeraldBoost Price TargetOverweight$263.00 ➝ $279.00Medium
i
7/29/2020BarclaysBoost Price TargetEqual Weight$245.00 ➝ $250.00Medium
i
7/28/2020Piper SandlerBoost Price TargetPositive ➝ Overweight$255.00 ➝ $270.00Medium
i
7/28/2020JPMorgan Chase & Co.Boost Price TargetNeutral$225.00 ➝ $232.00Medium
i
7/20/2020OppenheimerBoost Price TargetOutperform$252.00 ➝ $265.00Low
i
Rating by Jay Olson at Oppenheimer Holdings Inc.
7/20/2020Credit Suisse GroupBoost Price TargetOutperform$252.00 ➝ $290.00Low
i
7/15/2020Morgan StanleyBoost Price TargetOverweight$280.00 ➝ $285.00Low
i
6/18/2020JPMorgan Chase & Co.Boost Price TargetNeutral$219.00 ➝ $225.00Medium
i
6/2/2020SVB LeerinkBoost Price TargetMarket Perform$249.00 ➝ $253.00High
i
5/4/2020Cantor FitzgeraldBoost Price TargetOverweight$255.00 ➝ $263.00Low
i
Rating by Alethia Young at Cantor Fitzgerald
5/1/2020CfraBoost Price TargetBuy$223.00 ➝ $259.00Low
i
5/1/2020Bank of AmericaBoost Price TargetBuy$250.00 ➝ $265.00High
i
5/1/2020SVB LeerinkBoost Price TargetMarket Perform$219.00 ➝ $249.00High
i
5/1/2020Morgan StanleyBoost Price TargetOverweight$267.00 ➝ $280.00High
i
Rating by Matthew Harrison at Morgan Stanley
5/1/2020BMO Capital MarketsBoost Price TargetPositive ➝ Outperform$274.00 ➝ $291.00High
i
5/1/2020Wells Fargo & CompanyBoost Price TargetEqual Weight$220.00 ➝ $237.00High
i
5/1/2020OppenheimerInitiated CoverageBuy$252.00Medium
i
Rating by Jay Olson at Oppenheimer Holdings Inc.
4/30/2020MizuhoReiterated RatingHold$215.00Medium
i
Rating by Salim Syed at Mizuho
4/30/2020Piper SandlerBoost Price TargetOverweight$235.00 ➝ $255.00Medium
i
4/26/2020OppenheimerBoost Price TargetOutperform$240.00 ➝ $250.00Medium
i
4/15/2020Morgan StanleyLower Price TargetOverweight$277.00 ➝ $267.00Low
i
Rating by Matthew Harrison at Morgan Stanley
4/15/2020GuggenheimInitiated CoverageNeutral$225.00Low
i
3/31/2020Wolfe ResearchInitiated CoverageMarket Perform$218.00Medium
i
3/29/2020Raymond JamesUpgradeMarket Perform ➝ Outperform$255.00High
i
Rating by Dane Leone at Raymond James
3/26/2020OppenheimerLower Price TargetOutperform$250.00 ➝ $240.00High
i
3/13/2020CfraUpgradeHold ➝ BuyHigh
i
3/9/2020OppenheimerLower Price Target$256.00 ➝ $250.00Medium
i
Rating by Jason Helfstein at Oppenheimer Holdings Inc.
3/5/2020Bank of AmericaUpgradeNeutral ➝ Buy$245.00 ➝ $250.00Medium
i
2/27/2020BarclaysInitiated CoverageEqual Weight$235.00High
i
2/6/2020ArgusReiterated RatingBuy$265.00 ➝ $265.00Low
i
2/3/2020SunTrust BanksBoost Price TargetBuy ➝ Buy$254.00 ➝ $265.00Low
i
2/2/2020Credit Suisse GroupReiterated RatingBuy$252.00Low
i
Rating by Evan Seigerman at Credit Suisse Group AG
2/2/2020JPMorgan Chase & Co.Reiterated RatingNeutral ➝ HoldLow
i
Rating by Cory Kasimov at JPMorgan Chase & Co.
1/31/2020CfraBoost Price TargetHold$215.00 ➝ $223.00High
i
1/31/2020CowenReiterated RatingBuyHigh
i
Rating by Yaron Werber at Cowen Inc
1/31/2020Robert W. BairdDowngradeNeutral ➝ Underperform$173.00 ➝ $185.00High
i
1/30/2020MizuhoReiterated RatingHold$215.00High
i
Rating by Salim Syed at Mizuho
1/24/2020JPMorgan Chase & Co.Set Price TargetNeutral$198.00Low
i
Rating by Cory Kasimov at JPMorgan Chase & Co.
1/23/2020CitigroupBoost Price TargetBuy ➝ In-Line$245.00 ➝ $275.00Low
i
Rating by Mohit Bansal at Citigroup Inc.
1/22/2020UBS GroupBoost Price TargetNeutral$194.00 ➝ $238.00Low
i
1/21/2020OppenheimerBoost Price Target$250.00 ➝ $260.00Low
i
Rating by Jason Helfstein at Oppenheimer Holdings Inc.
1/21/2020Evercore ISIUpgradeIn-Line ➝ OutperformMedium
i
Rating by Umer Raffat at Evercore ISI
1/19/2020JPMorgan Chase & Co.Reiterated RatingHoldMedium
i
Rating by Cory Kasimov at JPMorgan Chase & Co.
1/17/2020Morgan StanleyLower Price TargetOverweight$280.00 ➝ $277.00Low
i
Rating by Matthew Harrison at Morgan Stanley
1/14/2020Cantor FitzgeraldReiterated RatingBuy$255.00Low
i
Rating by Alethia Young at Cantor Fitzgerald
1/9/2020BMO Capital MarketsBoost Price TargetOutperform$240.00 ➝ $275.00Low
i
Rating by Do Kim at BMO Capital Markets
12/23/2019Raymond JamesInitiated CoverageMarket PerformN/A
i
Rating by Dane Leone at Raymond James
12/19/2019CowenBoost Price TargetOutperform$253.00 ➝ $277.00Medium
i
Rating by Yaron Werber at Cowen Inc
12/17/2019Morgan StanleyInitiated CoverageOverweight$280.00Low
i
Rating by Matthew Harrison at Morgan Stanley
12/13/2019Credit Suisse GroupBoost Price TargetOutperform$235.00 ➝ $250.00Medium
i
Rating by Evan Seigerman at Credit Suisse Group AG
12/9/2019ArgusBoost Price TargetPositive ➝ Buy$240.00 ➝ $265.00Low
i
11/12/2019SunTrust BanksInitiated CoverageBuy$256.00Low
i
11/5/2019Cantor FitzgeraldUpgradeNeutral ➝ Overweight$230.00 ➝ $255.00Low
i
Rating by Alethia Young at Cantor Fitzgerald
10/30/2019SVB LeerinkBoost Price TargetMarket Perform$189.00 ➝ $205.00High
i
Rating by Geoff Porges at SVB Leerink LLC
10/16/2019Bank of AmericaInitiated CoverageNeutral$215.00Low
i
10/14/2019Sanford C. BernsteinInitiated CoverageOutperformLow
i
9/30/2019JPMorgan Chase & Co.Reiterated RatingHoldMedium
i
Rating by Cory Kasimov at JPMorgan Chase & Co.
9/30/2019The Goldman Sachs GroupSet Price TargetBuy$243.00Medium
i
Rating by Terence Flynn at The Goldman Sachs Group, Inc.
9/30/2019BMO Capital MarketsSet Price TargetBuy$240.00Medium
i
Rating by Do Kim at BMO Capital Markets
9/30/2019Cantor FitzgeraldSet Price TargetHold$230.00Medium
i
Rating by Alethia Young at Cantor Fitzgerald
9/30/2019SVB LeerinkSet Price TargetHold$189.00Medium
i
Rating by Geoff Porges at SVB Leerink LLC
9/30/2019Royal Bank of CanadaReiterated RatingHoldMedium
i
Rating by Kennen MacKay at Royal Bank of Canada
9/29/2019CowenSet Price TargetBuy$231.00Medium
i
Rating by Yaron Werber at Cowen Inc
9/29/2019MizuhoReiterated RatingHold$212.00Medium
i
Rating by Salim Syed at Mizuho
9/12/2019SVB LeerinkReiterated RatingHoldLow
i
Rating by Geoff Porges at SVB Leerink LLC
9/9/2019BMO Capital MarketsReiterated RatingBuyHigh
i
Rating by Do Kim at BMO Capital Markets
9/9/2019OppenheimerSet Price TargetBuy$240.00High
i
Rating by Jason Helfstein at Oppenheimer Holdings Inc.
9/6/2019JPMorgan Chase & Co.Set Price TargetHold$198.00High
i
Rating by Cory Kasimov at JPMorgan Chase & Co.
9/5/2019Cantor FitzgeraldReiterated RatingNeutral$221.00 ➝ $230.00Low
i
8/30/2019William BlairReiterated RatingHoldMedium
i
8/29/2019JPMorgan Chase & Co.Boost Price TargetNeutral$191.00 ➝ $198.00Low
i
Rating by Cory Kasimov at JPMorgan Chase & Co.
8/27/2019OppenheimerBoost Price Target$230.00 ➝ $240.00Low
i
Rating by Jay Olson at Oppenheimer Holdings Inc.
8/27/2019BMO Capital MarketsBoost Price TargetOutperform$230.00 ➝ $240.00Low
i
Rating by Do Kim at BMO Capital Markets
8/27/2019JPMorgan Chase & Co.Reiterated RatingHold$191.00 ➝ $198.00Low
i
Rating by Cory Kasimov at JPMorgan Chase & Co.
8/27/2019Wells Fargo & CompanyReiterated RatingMarket Perform$202.00 ➝ $220.00Low
i
Rating by Jim Birchenough at Wells Fargo & Company
8/27/2019Royal Bank of CanadaBoost Price TargetSector Perform$192.00 ➝ $206.00Low
i
Rating by Kennen MacKay at Royal Bank of Canada
8/26/2019Piper Jaffray CompaniesBoost Price TargetOverweight$210.00 ➝ $218.00Low
i
Rating by Christopher Raymond at Piper Jaffray Companies
8/22/2019CowenSet Price TargetBuy$231.00Low
i
Rating by Yaron Werber at Cowen Inc
8/21/2019Royal Bank of CanadaBoost Price TargetSector Perform$192.00Low
i
Rating by Kennen MacKay at Royal Bank of Canada
8/19/2019MizuhoDowngradeBuy ➝ Neutral$208.00 ➝ $212.00Low
i
Rating by Salim Syed at Mizuho
8/16/2019Credit Suisse GroupReiterated RatingOutperform$202.00 ➝ $225.00Low
i
Rating by Evan Seigerman at Credit Suisse Group AG
8/13/2019OppenheimerBoost Price TargetOutperform$210.00 ➝ $230.00Medium
i
Rating by Jay Olson at Oppenheimer Holdings Inc.
8/12/2019CitigroupReiterated RatingBuyLow
i
Rating by Mohit Bansal at Citigroup Inc.
8/12/2019Credit Suisse GroupSet Price TargetBuy$202.00Low
i
Rating by Evan Seigerman at Credit Suisse Group AG
8/12/2019Wells Fargo & CompanyBoost Price TargetMarket Perform ➝ Market Perform$197.00 ➝ $202.00High
i
8/11/2019Evercore ISIReiterated RatingHoldHigh
i
8/11/2019Royal Bank of CanadaReiterated RatingHoldHigh
i
8/10/2019Piper Jaffray CompaniesSet Price TargetBuy$210.00Low
i
Rating by Christopher Raymond at Piper Jaffray Companies
8/9/2019JPMorgan Chase & Co.Reiterated RatingHoldLow
i
Rating by Cory Kasimov at JPMorgan Chase & Co.
7/31/2019BMO Capital MarketsSet Price TargetBuy$230.00Low
i
Rating by Do Kim at BMO Capital Markets
7/15/2019Morgan StanleyLower Price TargetOverweight$211.00 ➝ $207.00Low
i
7/1/2019MizuhoReiterated RatingBuy$208.00Low
i
Rating by Salim Syed at Mizuho
6/24/2019MizuhoReiterated RatingBuy$208.00Low
i
Rating by Salim Syed at Mizuho
5/24/2019OppenheimerSet Price TargetBuy$210.00Medium
i
Rating by Jay Olson at Oppenheimer Holdings Inc.
5/22/2019CitigroupUpgradeNeutral ➝ Buy$211.00 ➝ $205.00Low
i
5/21/2019Royal Bank of CanadaReiterated RatingNeutral$192.00Low
i
5/20/2019Credit Suisse GroupInitiated CoverageOutperform$208.00 ➝ $208.00Low
i
5/17/2019MizuhoReiterated RatingBuy$208.00Low
i
Rating by Salim Syed at Mizuho
5/15/2019JPMorgan Chase & Co.Reiterated RatingHold$190.00Medium
i
Rating by Cory Kasimov at JPMorgan Chase & Co.
5/10/2019MizuhoSet Price TargetBuy$208.00High
i
Rating by Salim Syed at Mizuho
5/1/2019CowenReiterated RatingBuy$229.00High
i
4/22/2019MizuhoSet Price TargetBuy$208.00Low
i
Rating by Salim Syed at Mizuho
4/12/2019MizuhoSet Price TargetBuy$208.00Low
i
Rating by Salim Syed at Mizuho
4/1/2019Cantor FitzgeraldReiterated RatingHold$221.00Low
i
Rating by A. Young at Cantor Fitzgerald
3/22/2019MizuhoSet Price TargetBuy$208.00Low
i
Rating by Salim Syed at Mizuho
3/14/2019BMO Capital MarketsInitiated CoverageOutperform$228.00High
i
2/26/2019MizuhoReiterated RatingBuy$211.00Low
i
Rating by Salim Syed at Mizuho
2/26/2019CowenReiterated RatingBuy$234.00Low
i
2/13/2019MizuhoReiterated RatingBuy$211.00Low
i
Rating by Salim Syed at Mizuho
2/1/2019Royal Bank of CanadaReiterated RatingNeutralLow
i
1/30/2019SVB LeerinkLower Price TargetMarket Perform$200.00 ➝ $192.00High
i
Rating by Geoff Porges at SVB Leerink LLC
1/30/2019JPMorgan Chase & Co.Reiterated RatingNeutral$190.00High
i
Rating by Cory Kasimov at JPMorgan Chase & Co.
1/27/2019OppenheimerSet Price TargetBuy$224.00High
i
Rating by Jay Olson at Oppenheimer Holdings Inc.
1/17/2019The Goldman Sachs GroupReiterated RatingBuy$232.00Low
i
1/14/2019Royal Bank of CanadaReiterated RatingNeutral$182.00Low
i
1/4/2019CitigroupBoost Price TargetNeutral ➝ Neutral$204.00 ➝ $210.00Low
i
12/19/2018Morgan StanleyLower Price TargetOverweight ➝ Overweight$213.00 ➝ $212.00Medium
i
12/10/2018The Goldman Sachs GroupSet Price TargetBuy$232.00Low
i
12/4/2018Jefferies Financial GroupReiterated RatingBuy$220.00Medium
i
12/4/2018BarclaysReiterated RatingNeutral$195.00Medium
i
12/4/2018Cantor FitzgeraldReiterated RatingNeutral$223.00Medium
i
Rating by A. Young at Cantor Fitzgerald
12/4/2018JPMorgan Chase & Co.Set Price TargetNeutral$192.00Medium
i
Rating by Cory Kasimov at JPMorgan Chase & Co.
12/4/2018Royal Bank of CanadaReiterated RatingNeutral$182.00Medium
i
12/4/2018Morgan StanleyReiterated RatingBuy$213.00Medium
i
12/4/2018The Goldman Sachs GroupReiterated RatingBuy$232.00Medium
i
11/1/2018Royal Bank of CanadaReiterated RatingNeutralLow
i
11/1/2018CitigroupBoost Price TargetNeutral ➝ Neutral$200.00 ➝ $204.00Low
i
10/31/2018The Goldman Sachs GroupReiterated RatingBuy$221.00Low
i
10/31/2018Morgan StanleyBoost Price TargetOverweight ➝ Buy$212.00 ➝ $213.00Low
i
10/31/2018Royal Bank of CanadaLower Price TargetMarket Perform$182.00Low
i
10/31/2018Cantor FitzgeraldReiterated RatingHold$223.00Medium
i
Rating by A. Young at Cantor Fitzgerald
10/30/2018OppenheimerSet Price TargetBuy$224.00Medium
i
Rating by Leah R. Cann at Oppenheimer Holdings Inc.
10/26/2018MizuhoReiterated RatingBuy$206.00Low
i
Rating by Salim Syed at Mizuho
10/25/2018JPMorgan Chase & Co.Reiterated RatingNeutralLow
i
Rating by Cory Kasimov at JPMorgan Chase & Co.
10/12/2018The Goldman Sachs GroupReiterated RatingBuy$229.00Low
i
10/11/2018Morgan StanleyBoost Price TargetOverweight$210.00 ➝ $212.00Low
i
10/9/2018JPMorgan Chase & Co.Set Price TargetNeutral$192.00Low
i
10/8/2018Cantor FitzgeraldSet Price TargetNeutral$223.00Low
i
Rating by A. Young at Cantor Fitzgerald
10/8/2018Jefferies Financial GroupSet Price TargetBuy$220.00Low
i
10/2/2018OppenheimerReiterated RatingBuy$224.00Low
i
10/1/2018Jefferies Financial GroupReiterated RatingBuy$220.00Medium
i
10/1/2018Cantor FitzgeraldInitiated CoverageNeutral ➝ Neutral$223.00Low
i
Rating by A. Young at Cantor Fitzgerald
9/28/2018Royal Bank of CanadaSet Price TargetNeutral$193.00Low
i
9/17/2018SVB LeerinkSet Price TargetHold$209.00Low
i
Rating by Geoff Porges at SVB Leerink LLC
9/12/2018Jefferies Financial GroupSet Price TargetBuy$220.00Low
i
9/10/2018OppenheimerSet Price TargetBuy$224.00High
i
9/10/2018Royal Bank of CanadaReiterated RatingNeutral$193.00High
i
9/6/2018Jefferies Financial GroupSet Price TargetBuy$220.00Low
i
8/29/2018Wells Fargo & CompanyReiterated RatingNeutral$197.00Medium
i
8/28/2018OppenheimerReiterated RatingBuy$224.00Low
i
8/24/2018Jefferies Financial GroupReiterated RatingBuy$220.00Low
i
7/30/2018MorningstarSet Price TargetNeutral$198.00Low
i
7/30/2018Wells Fargo & CompanyReiterated RatingNeutral$197.00Low
i
7/30/2018OppenheimerReiterated RatingBuy$224.00Low
i
7/30/2018Robert W. BairdBoost Price TargetNeutral ➝ Neutral$165.00 ➝ $179.00Low
i
7/30/2018CitigroupBoost Price TargetNeutral ➝ Neutral$188.00 ➝ $200.00Low
i
7/27/2018MizuhoReiterated RatingBuy$200.00Low
i
Rating by Salim Syed at Mizuho
7/27/2018The Goldman Sachs GroupReiterated RatingBuy$228.00Low
i
7/27/2018Royal Bank of CanadaSet Price TargetBuy$193.00Low
i
7/27/2018Jefferies Financial GroupBoost Price TargetBuy ➝ Buy$200.00 ➝ $220.00High
i
7/27/2018JPMorgan Chase & Co.Boost Price TargetNeutral ➝ Neutral$191.00 ➝ $192.00High
i
7/26/2018Piper Jaffray CompaniesBoost Price TargetIn-Line ➝ Overweight$190.00 ➝ $210.00High
i
7/16/2018Jefferies Financial GroupReiterated RatingBuy$200.00Low
i
7/13/2018Morgan StanleyBoost Price TargetBuy$200.00 ➝ $210.00Low
i
6/22/2018MizuhoReiterated RatingBuy$200.00Low
i
Rating by Salim Syed at Mizuho
5/15/2018MizuhoSet Price TargetBuy$200.00High
i
Rating by Salim Syed at Mizuho
4/25/2018Morgan StanleyLower Price TargetOverweight ➝ Overweight$205.00 ➝ $200.00Medium
i
4/25/2018Royal Bank of CanadaLower Price TargetSector Perform$183.00High
i
4/24/2018MizuhoSet Price TargetBuy$200.00High
i
Rating by Salim Syed at Mizuho
4/24/2018CowenReiterated RatingBuy$204.00Medium
i
4/5/2018BarclaysLower Price TargetEqual Weight ➝ Equal Weight$190.00 ➝ $180.00Low
i
2/12/2018MizuhoBoost Price TargetBuy ➝ Buy$192.00 ➝ $200.00Low
i
Rating by Salim Syed at Mizuho
2/5/2018Atlantic SecuritiesDowngradeOverweight ➝ Neutral$187.01High
i
2/4/2018JPMorgan Chase & Co.Reiterated RatingHold$191.00High
i
2/2/2018SVB LeerinkReiterated RatingMarket PerformHigh
i
Rating by G. Porges at SVB Leerink LLC
2/2/2018CowenReiterated RatingBuy$204.00Low
i
2/2/2018Credit Suisse GroupBoost Price TargetNeutral ➝ Neutral$191.00 ➝ $194.00Low
i
2/2/2018BMO Capital MarketsBoost Price TargetMarket Perform ➝ Market Perform$192.00 ➝ $202.00Medium
i
2/2/2018Morgan StanleyLower Price TargetOverweight ➝ Overweight$204.00 ➝ $196.00Medium
i
2/2/2018Piper Jaffray CompaniesLower Price TargetOverweight ➝ Overweight$194.00 ➝ $190.00Medium
i
2/1/2018MizuhoReiterated RatingBuy$192.00High
i
Rating by Salim Syed at Mizuho
1/30/2018OppenheimerReiterated RatingBuy$205.00 ➝ $205.00Low
i
Rating by Leah R. Cann at Oppenheimer Holdings Inc.
1/24/2018JPMorgan Chase & Co.Boost Price TargetNeutral ➝ Neutral$184.00 ➝ $189.00Low
i
1/24/2018Royal Bank of CanadaReiterated RatingHold$189.00Low
i
1/23/2018ArgusUpgradeHold ➝ Buy$192.33 ➝ $220.00Low
i
1/5/2018OppenheimerSet Price TargetBuy$205.00Low
i
Rating by Leah R. Cann at Oppenheimer Holdings Inc.
1/2/2018Piper Jaffray CompaniesReiterated RatingBuyLow
i
12/28/2017MizuhoSet Price TargetBuy$192.00Low
i
Rating by Salim Syed at Mizuho
12/22/2017MizuhoSet Price TargetBuy$192.00Low
i
Rating by Salim Syed at Mizuho
12/18/2017CitigroupDowngradeNeutralLow
i
12/15/2017The Goldman Sachs GroupDowngradeConviction-Buy ➝ BuyHigh
i
12/12/2017OppenheimerSet Price TargetBuy$205.00Low
i
Rating by Leah R. Cann at Oppenheimer Holdings Inc.
11/30/2017OppenheimerReiterated RatingBuy$205.00Low
i
Rating by Leah R. Cann at Oppenheimer Holdings Inc.
11/1/2017ArgusDowngradeBuy ➝ Hold$175.22 ➝ $195.00N/A
i
10/29/2017MizuhoSet Price TargetBuy$198.00N/A
i
Rating by Salim Syed at Mizuho
10/26/2017BMO Capital MarketsReiterated RatingMarket Perform$198.00N/A
i
10/26/2017Morgan StanleyLower Price TargetOverweight$196.00 ➝ $193.00N/A
i
10/26/2017Royal Bank of CanadaLower Price TargetSector Perform$192.00 ➝ $188.00N/A
i
10/20/2017BMO Capital MarketsReiterated RatingHold$198.00N/A
i
10/13/2017BarclaysBoost Price TargetEqual Weight$180.00 ➝ $190.00N/A
i
10/6/2017OppenheimerReiterated RatingBuy$203.00N/A
i
Rating by Leah R. Cann at Oppenheimer Holdings Inc.
10/6/2017MizuhoReiterated RatingBuy$198.00N/A
i
Rating by Salim Syed at Mizuho
10/6/2017Morgan StanleyReiterated RatingOverweight$189.00 ➝ $196.00N/A
i
10/5/2017Bank of AmericaBoost Price TargetBuy$210.00N/A
i
9/29/2017Credit Suisse GroupReiterated RatingNeutral$177.00 ➝ $186.00Medium
i
Rating by Alethia Young at Credit Suisse Group AG
9/28/2017MizuhoReiterated RatingBuy ➝ Buy$183.00 ➝ $198.00Low
i
Rating by Salim Syed at Mizuho
9/25/2017Jefferies Financial GroupReiterated RatingBuy$200.00Low
i
9/25/2017BMO Capital MarketsReiterated RatingHold$199.00Low
i
9/14/2017Royal Bank of CanadaInitiated CoverageSector Perform ➝ Sector Perform$192.00High
i
9/7/2017OppenheimerReiterated RatingBuy$203.00Low
i
Rating by Leah R. Cann at Oppenheimer Holdings Inc.
8/21/2017MizuhoReiterated RatingBuy$195.00 ➝ $183.00Low
i
Rating by Salim Syed at Mizuho
7/27/2017ArgusBoost Price TargetBuy$180.00 ➝ $195.00Low
i
Rating by Jacob Kilstein at Argus
7/26/2017UBS GroupSet Price TargetHold$175.00 ➝ $180.00High
i
Rating by Carter Gould at UBS Group AG
7/26/2017OppenheimerReiterated RatingOutperform$189.00 ➝ $203.00Low
i
Rating by Leah R. Cann at Oppenheimer Holdings Inc.
7/26/2017Deutsche Bank AktiengesellschaftReiterated RatingHold$172.00 ➝ $174.00Low
i
Rating by Andrew Peters at Deutsche Bank Aktiengesellschaft
7/26/2017BMO Capital MarketsDowngradeOutperform ➝ Market PerformLow
i
7/22/2017CowenReiterated RatingOutperform$209.00Low
i
7/21/2017BMO Capital MarketsDowngradeOutperform ➝ Market Perform$199.00Low
i
7/17/2017Jefferies Financial GroupReiterated RatingBuy$195.00Low
i
7/14/2017Credit Suisse GroupSet Price TargetHold$177.00Low
i
Rating by Alethia Young at Credit Suisse Group AG
7/14/2017OppenheimerReiterated RatingOutperform$189.00Low
i
Rating by Leah R. Cann at Oppenheimer Holdings Inc.
7/11/2017Jefferies Financial GroupReiterated RatingBuy ➝ Buy$195.00Low
i
7/10/2017Morgan StanleyReiterated RatingOverweightLow
i
7/9/2017MizuhoReiterated RatingBuy$195.00Low
i
Rating by Salim Syed at Mizuho
6/30/2017OppenheimerReiterated RatingOutperform$189.00Low
i
Rating by Leah R. Cann at Oppenheimer Holdings Inc.
6/26/2017William BlairReiterated RatingMarket PerformLow
i
Rating by M. Phipps at William Blair
6/23/2017Deutsche Bank AktiengesellschaftInitiated CoverageHold$172.00Medium
i
6/22/2017SVB LeerinkReiterated RatingMarket Perform$161.00Low
i
Rating by Geoff Porges at SVB Leerink LLC
6/13/2017UBS GroupReiterated RatingNeutral$174.00 ➝ $175.00N/A
i
Rating by Carter Gould at UBS Group AG
6/13/2017OppenheimerSet Price TargetBuy$189.00Low
i
Rating by Leah R. Cann at Oppenheimer Holdings Inc.
6/13/2017Morgan StanleyBoost Price TargetOverweight$183.00 ➝ $184.00Low
i
6/8/2017Sanford C. BernsteinSet Price TargetHold$164.00Medium
i
Rating by Ronny Gal at Sanford C. Bernstein
6/5/2017OppenheimerSet Price TargetBuy$189.00Low
i
Rating by Leah R. Cann at Oppenheimer Holdings Inc.
5/22/2017Credit Suisse GroupSet Price TargetHold$177.00Low
i
Rating by Alethia Young at Credit Suisse Group AG
5/22/2017SVB LeerinkSet Price TargetHold$159.00Low
i
Rating by Geoff Porges at SVB Leerink LLC
5/22/2017BMO Capital MarketsReiterated RatingBuy$200.00 ➝ $198.00Low
i
5/22/2017UBS GroupReiterated RatingNeutral$175.00 ➝ $174.00N/A
i
Rating by Carter Gould at UBS Group AG
5/22/2017Jefferies Financial GroupReiterated RatingHold$180.00Low
i
5/19/2017OppenheimerReiterated RatingOutperform$189.00Low
i
Rating by Leah R. Cann at Oppenheimer Holdings Inc.
5/9/2017OppenheimerSet Price TargetBuy$189.00Low
i
Rating by Leah R. Cann at Oppenheimer Holdings Inc.
5/6/2017MizuhoSet Price TargetBuy$195.00Low
i
Rating by Salim Syed at Mizuho
4/28/2017Robert W. BairdReiterated RatingNeutral$165.00Low
i
4/27/2017CowenReiterated RatingBuy$209.00Low
i
4/25/2017Sanford C. BernsteinReiterated RatingMarket Perform$178.00Low
i
4/19/2017CowenReiterated RatingOutperform$209.00Low
i
4/6/2017OppenheimerReiterated RatingOutperform$189.00Low
i
Rating by Leah R. Cann at Oppenheimer Holdings Inc.
4/5/2017Jefferies Financial GroupDowngradeBuy ➝ Hold$194.00 ➝ $180.00Low
i
4/4/2017Credit Suisse GroupReiterated RatingHold$178.00Low
i
Rating by Alethia Young at Credit Suisse Group AG
4/3/2017MizuhoReiterated RatingBuy$195.00Low
i
Rating by Salim Syed at Mizuho
3/20/2017The Goldman Sachs GroupLower Price TargetConviction-Buy$208.00 ➝ $202.00Low
i
3/17/2017Robert W. BairdReiterated RatingNeutral$165.00Low
i
3/17/2017CowenReiterated RatingBuy$209.00Medium
i
3/16/2017MizuhoSet Price TargetBuy$195.00High
i
Rating by Salim Syed at Mizuho
3/14/2017OppenheimerReiterated RatingOutperform$189.00Low
i
Rating by Leah R. Cann at Oppenheimer Holdings Inc.
3/14/2017Piper Jaffray CompaniesReiterated RatingOverweight$193.00Low
i
Rating by joshua schimmer at Piper Jaffray Companies
3/10/2017MizuhoSet Price TargetBuy$195.00N/A
i
3/9/2017UBS GroupInitiated CoverageNeutral ➝ Neutral$185.00N/A
i
3/6/2017OppenheimerSet Price TargetBuy$189.00N/A
i
Rating by Leah R. Cann at Oppenheimer Holdings Inc.
3/6/2017BMO Capital MarketsReiterated RatingOutperform$212.00N/A
i
2/28/2017OppenheimerSet Price TargetBuy$189.00N/A
i
Rating by Leah R. Cann at Oppenheimer Holdings Inc.
2/22/2017OppenheimerReiterated RatingOutperform$175.00N/A
i
Rating by Leah R. Cann at Oppenheimer Holdings Inc.
2/14/2017OppenheimerSet Price TargetBuy$175.00N/A
i
Rating by Leah R. Cann at Oppenheimer Holdings Inc.
2/13/2017BMO Capital MarketsBoost Price TargetOutperform$202.00 ➝ $212.00N/A
i
2/11/2017ArgusSet Price TargetBuy$195.00N/A
i
Rating by Jacob Kilstein at Argus
2/8/2017MizuhoReiterated RatingBuyN/A
i
2/5/2017Credit Suisse GroupReiterated RatingHold$178.00N/A
i
Rating by Alethia Young at Credit Suisse Group AG
2/3/2017BMO Capital MarketsBoost Price TargetPositive$197.00 ➝ $202.00N/A
i
2/3/2017Jefferies Financial GroupReiterated RatingBuy$198.00 ➝ $194.00N/A
i
2/2/2017OppenheimerSet Price TargetBuy$166.00 ➝ $175.00N/A
i
Rating by Leah R. Cann at Oppenheimer Holdings Inc.
2/1/2017Bank of AmericaUpgradeNeutral ➝ Buy$156.68 ➝ $192.00N/A
i
1/31/2017Royal Bank of CanadaSet Price TargetBuy$190.00N/A
i
Rating by Michael Yee at Royal Bank of Canada
1/27/2017OppenheimerSet Price TargetBuy$166.00N/A
i
Rating by Leah R. Cann at Oppenheimer Holdings Inc.
1/10/2017SVB LeerinkReiterated RatingMarket PerformN/A
i
Rating by Geoff Porges at SVB Leerink LLC
1/9/2017BMO Capital MarketsReiterated RatingBuy$197.00N/A
i
1/8/2017Robert W. BairdReiterated RatingNeutral$157.00 ➝ $165.00N/A
i
1/6/2017The Goldman Sachs GroupReiterated RatingPositive$202.00 ➝ $218.00N/A
i
1/4/2017Royal Bank of CanadaSet Price TargetBuy$190.00N/A
i
Rating by Michael Yee at Royal Bank of Canada
12/20/2016Credit Suisse GroupDowngradeOutperform ➝ Neutral$200.00 ➝ $180.00N/A
i
Rating by alethia young at Credit Suisse Group AG
12/13/2016Chardan CapitalUpgradeSell ➝ NeutralN/A
i
12/13/2016OppenheimerInitiated CoverageOutperform$166.00 ➝ $166.00N/A
i
11/21/2016SVB LeerinkSet Price TargetHold$163.00N/A
i
Rating by Geoff Porges at SVB Leerink LLC
11/7/2016MizuhoInitiated CoverageBuy$164.00N/A
i
10/30/2016Royal Bank of CanadaSet Price TargetBuy$190.00N/A
i
Rating by Michael Yee at Royal Bank of Canada
10/28/2016SVB LeerinkReiterated RatingMarket Perform$193.00 ➝ $163.00N/A
i
Rating by geoff porges at SVB Leerink LLC
9/28/2016Jefferies Financial GroupReiterated RatingBuyN/A
i
Rating by Eun Yang at Jefferies Financial Group Inc.
9/28/2016CitigroupLower Price TargetNeutral$175.00 ➝ $172.00N/A
i
9/28/2016JPMorgan Chase & Co.Reiterated RatingHoldN/A
i
9/27/2016The Goldman Sachs GroupReiterated RatingBuy$204.00 ➝ $206.00N/A
i
Rating by Terence Flynn at The Goldman Sachs Group, Inc.
9/22/2016BMO Capital MarketsReiterated RatingOutperform$190.00N/A
i
Rating by Ian Somaiya at BMO Capital Markets
9/20/2016Jefferies Financial GroupReiterated RatingBuy$198.00N/A
i
Rating by Eun Yang at Jefferies Financial Group Inc.
9/19/2016CowenReiterated RatingBuyN/A
i
Rating by Eric Schmidt at Cowen Inc
9/17/2016SVB LeerinkReiterated RatingHoldN/A
i
Rating by geoff porges at SVB Leerink LLC
9/17/2016Credit Suisse GroupSet Price TargetBuy$206.00N/A
i
Rating by alethia young at Credit Suisse Group AG
9/15/2016Piper Jaffray CompaniesSet Price TargetBuy$193.00N/A
i
Rating by joshua schimmer at Piper Jaffray Companies
9/11/2016SVB LeerinkReiterated RatingHold$193.00N/A
i
Rating by geoff porges at SVB Leerink LLC
9/8/2016The Goldman Sachs GroupReiterated RatingBuy$204.00N/A
i
Rating by Terence Flynn at The Goldman Sachs Group, Inc.
8/26/2016SVB LeerinkReiterated RatingMarket Perform$201.00N/A
i
Rating by Geoff Porges at SVB Leerink LLC
8/26/2016Morgan StanleyReiterated RatingOverweight$199.00 ➝ $198.00N/A
i
Rating by Matthew Harrison at Morgan Stanley
8/26/2016GabelliInitiated CoverageHoldN/A
i
Rating by J. He at Gabelli
8/26/2016Robert W. BairdReiterated RatingOutperform$157.00N/A
i
Rating by Brian Skorney at Robert W. Baird
8/23/2016Jefferies Financial GroupReiterated RatingBuy$198.00N/A
i
Rating by Eun Yang at Jefferies Financial Group Inc.
8/5/2016ArgusReiterated RatingBuy$185.00 ➝ $195.00N/A
i
8/3/2016Jefferies Financial GroupReiterated RatingBuyN/A
i
Rating by Eun Yang at Jefferies Financial Group Inc.
7/29/2016CitigroupBoost Price TargetNeutral$165.00 ➝ $175.00N/A
i
Rating by Robyn Karnauskas at Citigroup Inc.
7/28/2016BarclaysReiterated RatingEqual Weight$185.00N/A
i
7/28/2016Piper Jaffray CompaniesReiterated RatingBuy$193.00N/A
i
Rating by Joshua Schimmer at Piper Jaffray Companies
7/28/2016Morgan StanleyBoost Price TargetOverweight$198.00 ➝ $199.00N/A
i
Rating by Matthew Harrison at Morgan Stanley
7/28/2016Jefferies Financial GroupBoost Price TargetBuy$187.00 ➝ $198.00N/A
i
7/28/2016Credit Suisse GroupReiterated RatingBuy$206.00N/A
i
Rating by Alethia Young at Credit Suisse Group AG
7/28/2016SVB LeerinkReiterated RatingMarket Perform$186.00 ➝ $201.00N/A
i
Rating by Geoff Porges at SVB Leerink LLC
7/28/2016BMO Capital MarketsReiterated RatingOutperform$186.00 ➝ $190.00N/A
i
Rating by Ian Somaiya at BMO Capital Markets
7/28/2016Robert W. BairdReiterated RatingNeutral$157.00N/A
i
Rating by Brian Skorney at Robert W. Baird
7/15/2016Robert W. BairdReiterated RatingNeutral$157.00N/A
i
Rating by Brian Skorney at Robert W. Baird
7/13/2016Bank of AmericaReiterated RatingHold$182.00N/A
i
Rating by Ying Huang at Bank of America Co.
7/13/2016Jefferies Financial GroupReiterated RatingBuy$187.00N/A
i
7/12/2016BMO Capital MarketsReiterated RatingBuy$186.00N/A
i
Rating by Ian Somaiya at BMO Capital Markets
6/29/2016The Goldman Sachs GroupReiterated RatingBuyN/A
i
Rating by Terence Flynn at The Goldman Sachs Group, Inc.
6/29/2016Morgan StanleyReiterated RatingOverweightN/A
i
Rating by Matthew Harrison at Morgan Stanley
6/29/2016Sanford C. BernsteinInitiated CoverageMarket Perform$161.00N/A
i
6/26/2016SVB LeerinkReiterated RatingHoldN/A
i
Rating by Geoff Porges at SVB Leerink LLC
6/15/2016The Goldman Sachs GroupReiterated RatingBuy$202.00N/A
i
6/9/2016SVB LeerinkReiterated RatingMarket Perform$186.00N/A
i
Rating by Howard Liang at SVB Leerink LLC
6/9/2016BMO Capital MarketsReiterated RatingOutperform$186.00N/A
i
Rating by Ian Somaiya at BMO Capital Markets
6/8/2016Bank of AmericaReiterated RatingHold$182.00N/A
i
Rating by Ying Huang at Bank of America Co.
5/19/2016Bank of AmericaReiterated RatingHoldN/A
i
Rating by Ying Huang at Bank of America Co.
5/19/2016Morgan StanleyReiterated RatingBuyN/A
i
Rating by Matthew Harrison at Morgan Stanley
5/18/2016Royal Bank of CanadaReiterated RatingBuyN/A
i
Rating by Michael Yee at Royal Bank of Canada
5/16/2016Robert W. BairdReiterated RatingHoldN/A
i
Rating by Brian Skorney at Robert W. Baird
5/10/2016Piper Jaffray CompaniesReiterated RatingBuyN/A
i
Rating by Joshua Schimmer at Piper Jaffray Companies
5/1/2016SVB LeerinkReiterated RatingMarket Perform$179.00 ➝ $186.00N/A
i
Rating by Howard Liang at SVB Leerink LLC
4/30/2016Piper Jaffray CompaniesReiterated RatingBuyN/A
i
Rating by Joshua Schimmer at Piper Jaffray Companies
4/30/2016BMO Capital MarketsReiterated RatingBuy$183.00 ➝ $186.00N/A
i
Rating by Ian Somaiya at BMO Capital Markets
4/29/2016Morgan StanleyReiterated RatingBuy$195.00N/A
i
Rating by Matthew Harrison at Morgan Stanley
4/17/2016CowenReiterated RatingBuyN/A
i
Rating by Eric Schmidt at Cowen Inc
4/8/2016Morgan StanleyBoost Price Target$193.00 ➝ $195.00N/A
i
Rating by Matthew Harrison at Morgan Stanley
4/5/2016BMO Capital MarketsInitiated CoverageOutperform$183.00N/A
i
4/5/2016SVB LeerinkReiterated RatingMarket PerformN/A
i
Rating by Howard Liang at SVB Leerink LLC
3/29/2016Morgan StanleyReiterated RatingOverweight$193.00N/A
i
Rating by Matthew Harrison at Morgan Stanley
3/16/2016Royal Bank of CanadaReiterated RatingBuy$190.00N/A
i
Rating by Michael Yee at Royal Bank of Canada
3/16/2016Piper Jaffray CompaniesReiterated RatingOverweight$191.00N/A
i
Rating by Joshua Schimmer at Piper Jaffray Companies
3/8/2016CowenReiterated RatingOutperform$193.00N/A
i
Rating by Eric Schmidt at Cowen Inc
3/3/2016Piper Jaffray CompaniesReiterated RatingBuy$200.00 ➝ $191.00N/A
i
Rating by Joshua Schimmer at Piper Jaffray Companies
2/25/2016CitigroupInitiated CoverageNeutral$165.00N/A
i
2/23/2016BTIG ResearchReiterated RatingSell$135.00N/A
i
Rating by Hartaj Singh at BTIG Research
2/22/2016CowenReiterated RatingOutperform$193.00N/A
i
Rating by Eric Schmidt at Cowen Inc
2/22/2016JPMorgan Chase & Co.Reiterated RatingNeutral$165.00N/A
i
Rating by Cory Kasimov at JPMorgan Chase & Co.
2/22/2016The Goldman Sachs GroupLower Price Target$218.00 ➝ $201.00N/A
i
2/11/2016Jefferies Financial GroupReiterated RatingBuy$187.00N/A
i
2/11/2016Jefferies Financial GroupLower Price TargetBuy$187.00N/A
i
Rating by Eun Yang at Jefferies Financial Group Inc.
2/8/2016ArgusLower Price TargetBuy$202.00 ➝ $185.00N/A
i
2/6/2016SVB LeerinkReiterated RatingHoldN/A
i
Rating by Geoff Porges at SVB Leerink LLC
2/4/2016SVB LeerinkInitiated CoverageMarket Perform$179.00N/A
i
1/29/2016Credit Suisse GroupReiterated RatingBuyN/A
i
1/29/2016Morgan StanleyBoost Price Target$189.00 ➝ $193.00N/A
i
Rating by Matthew Harrison at Morgan Stanley
1/29/2016JPMorgan Chase & Co.Lower Price TargetNeutral$174.00 ➝ $165.00N/A
i
Rating by Cory Kasimov at JPMorgan Chase & Co.
1/29/2016The Goldman Sachs GroupBoost Price Target$213.00 ➝ $218.00N/A
i
1/28/2016CowenReiterated RatingBuyN/A
i
Rating by Eric Schmidt at Cowen Inc
1/28/2016Piper Jaffray CompaniesReiterated RatingBuy$200.00N/A
i
Rating by Joshua Schimmer at Piper Jaffray Companies
1/28/2016JPMorgan Chase & Co.Reiterated RatingNeutral$174.00 ➝ $165.00N/A
i
Rating by Cory Kasimov at JPMorgan Chase & Co.
1/26/2016UBS GroupReiterated RatingBuy$180.00N/A
i
Rating by Matt Roden at UBS Group AG
1/22/2016Wells Fargo & CompanyReiterated RatingHoldN/A
i
1/19/2016Credit Suisse GroupInitiated CoverageOutperform$205.00N/A
i
1/13/2016JPMorgan Chase & Co.Reiterated RatingNeutralN/A
i
Rating by Cory Kasimov at JPMorgan Chase & Co.
1/9/2016Jefferies Financial GroupReiterated RatingBuyN/A
i
Rating by Eun Yang at Jefferies Financial Group Inc.
1/8/2016Piper Jaffray CompaniesReiterated RatingBuy$200.00N/A
i
Rating by Joshua Schimmer at Piper Jaffray Companies
1/7/2016BTIG ResearchInitiated CoverageSell$135.00N/A
i
12/18/2015Atlantic SecuritiesInitiated CoverageOverweight$202.00N/A
i
12/14/2015Morgan StanleyUpgradeEqual Weight ➝ Overweight$160.00 ➝ $193.00N/A
i
12/9/2015JPMorgan Chase & Co.Reiterated RatingNeutral$174.00N/A
i
12/4/2015Wells Fargo & CompanyInitiated CoverageMarket PerformN/A
i
(Data available from 11/25/2015 forward)
Amgen logo
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta, a pegylated protein to treat cancer patients; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Sensipar/Mimpara to treat secondary hyperparathyroidism; and EPOGEN to treat anemia caused by chronic kidney disease. It also markets other products in various markets, including Nplate, Vectibix, Repatha, Parsabiv, BLINCYTO, Aimovig, NEUPOGEN, Otezla, AMGEVITA, KANJINTI, EVENITY, IMLYGIC, MVASI, and Corlanor. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with Novartis; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; QIAGEN N.V.; Adaptive Biotechnologies; and Eli Lilly and Company. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
Read More

Today's Range

Now: $220.46
$219.82
$223.05

50 Day Range

MA: $231.72
$216.38
$257.67

52 Week Range

Now: $220.46
$177.05
$264.97

Volume

3,104,950 shs

Average Volume

2,842,271 shs

Market Capitalization

$128.34 billion

P/E Ratio

17.78

Dividend Yield

2.88%

Beta

0.81